INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![Automation software technology-GettyImages-1367967285]( "Rethinking Liquid Handling Automation")
Rethinking Liquid Handling AutomationLabs today require more than precision—they need systems built for flexibility, reproducibility, and trust. Explore how automation is evolving to meet the real-world needs of modern scientific teams
-
![Virtual Pharm Expo]( "Syntegon Virtual Pharma Expo May 2025: Aseptic Manufacturing And Packaging")
Syntegon Virtual Pharma Expo May 2025: Aseptic Manufacturing And PackagingThe 2022 EU GMP Annex 1 revision marks a pivotal shift in sterile manufacturing, emphasizing contamination control, advanced technologies, and global harmonization—driving industry-wide adaptation and regulatory interpretation challenges.
-
![Bora Pharmaceuticals]( "Commercially Proven Sterile Fill/Finish With Capacity And Global Backing")
Commercially Proven Sterile Fill/Finish With Capacity And Global BackingFind comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.
-
![GettyImages-1462147534 manufacturing]( "Fluid Management Strategies For Scalable Biopharmaceutical Production")
Fluid Management Strategies For Scalable Biopharmaceutical ProductionEffective fluid management systems are indispensable in therapeutic manufacturing. Discover how modular design, automation, and single-use systems enhance scalability and maintain product integrity.
-
AST Origins: Pioneering RTU Flexibility With Robotic Fill-Finish Systems3/25/2026
Modernize sterile manufacturing with robotic fill-finish systems. Achieve multi-format flexibility and risk reduction to meet the rigorous demands of personalized medicine and small-batch production.
-
NanoImprove The Performance Of Your Formulations9/24/2024
Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.
-
Accelerating Sterile Injectable Innovation Through Strategic Outsourcing9/21/2025
Sterile injectables are vital for modern medicine. Learn how outsourcing manufacturing to a CDMO can accelerate development and commercialization.
-
Demystifying Lyophilization: Understanding The Freeze-Drying Process5/23/2024
Advancements in lyophilization technology and research have helped overcome inherent challenges and ensure the safety and efficacy of lyophilized pharmaceuticals.
-
Afton Scientific Capabilities Update January 2026: Fill/Finish1/27/2026
Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Bowie Dick Simulation Test]( "Reusable PCD Designed For Routine Monitoring")
Reusable Process Challenge Device (PCD) designed for routine monitoring of pre-vacuum steam sterilizers.
-
![Pharmaceutical Glove Isolator Tester FZ-GTS 4.0]( "Pharmaceutical Glove Isolator Tester: FZ-GTS 4.0")
Maximize glove testing efficiency
Improve your glove testing with the FZ-GTS 4.0. This innovative system delivers unmatched flexibility to adapt to your testing needs, seamlessly integrating with existing workflows for increased efficiency.
-
![Filamatic Filler, Model DAB-32-4]( "Used Filamatic Aseptic Filling System: Model DAB-32-4")
Used Filamatic piston filler, model DAB-32-4, with (2) fill heads with pumps, on stand, 220 volt, serial# 022942.
-
![cell and gene]( "Cell And Gene Therapy Development Aseptic R&D Filling Equipment")
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
-
![Esco- Streamline Compounding Isolator (SCI)]( "Compounding Aseptic Containment Isolators")
Ensure sterile integrity and personnel safety during hazardous drug handling. Optimize workflows with advanced containment technology that adapts to complex facility and processing requirements.
